Movement Alert｜Boston Scientific Rises 3.01% in Regular Trading, Sector Strength and Post-Earnings Recovery Drive Gains

Market Focus08-11

On August 11, Boston Scientific rose 3.01% in regular trading, trading at $50.795/share, with turnover of $692 million. The rally was driven by broad strength in the Health Care Equipment sector combined with continued recovery following the company's better-than-expected Q2 earnings.

Boston Scientific reported Q2 adjusted EPS of $0.86, beating the consensus estimate of $0.83 by 3.6%, while net sales of $5.44 billion also exceeded the $5.36 billion expected. The outperformance was fueled by strong growth in interventional cardiology and neuromodulation, with the latter posting 12.7% sales growth. However, the company lowered its full-year adjusted EPS guidance to $3.28-$3.32 versus the Street estimate of $3.36, citing headwinds from Watchman device utilization slowdown and intensifying electrophysiology competition. Despite the guidance cut, multiple firms including UBS, Deutsche Bank, and RBC maintained buy ratings while trimming price targets. The Health Care Equipment sector rallied broadly on the day, with DexCom up 3.76%, Intuitive Surgical up 2.99%, and Medtronic up 2.21%, providing additional support.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1149687835?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-11 03:21","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1149687835","market":"us","top_or_hot":-1,"title":"Movement Alert｜Boston Scientific Rises 3.01% in Regular Trading, Sector Strength and Post-Earnings Recovery Drive Gains","media":"Market Focus","content":"<p><p>On August 11, Boston Scientific rose 3.01% in regular trading, trading at $50.795/share, with turnover of $692 million. The rally was driven by broad strength in the Health Care Equipment sector combined with continued recovery following the company's better-than-expected Q2 earnings.</p><p>Boston Scientific reported Q2 adjusted EPS of $0.86, beating the consensus estimate of $0.83 by 3.6%, while net sales of $5.44 billion also exceeded the $5.36 billion expected. The outperformance was fueled by strong growth in interventional cardiology and neuromodulation, with the latter posting 12.7% sales growth. However, the company lowered its full-year adjusted EPS guidance to $3.28-$3.32 versus the Street estimate of $3.36, citing headwinds from Watchman device utilization slowdown and intensifying electrophysiology competition. Despite the guidance cut, multiple firms including UBS, Deutsche Bank, and RBC maintained buy ratings while trimming price targets. The Health Care Equipment sector rallied broadly on the day, with DexCom up 3.76%, Intuitive Surgical up 2.99%, and Medtronic up 2.21%, providing additional support.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜Boston Scientific Rises 3.01% in Regular Trading, Sector Strength and Post-Earnings Recovery Drive Gains</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜Boston Scientific Rises 3.01% in Regular Trading, Sector Strength and Post-Earnings Recovery Drive Gains\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-08-11 03:21</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On August 11, Boston Scientific rose 3.01% in regular trading, trading at $50.795/share, with turnover of $692 million. The rally was driven by broad strength in the Health Care Equipment sector combined with continued recovery following the company's better-than-expected Q2 earnings.</p><p>Boston Scientific reported Q2 adjusted EPS of $0.86, beating the consensus estimate of $0.83 by 3.6%, while net sales of $5.44 billion also exceeded the $5.36 billion expected. The outperformance was fueled by strong growth in interventional cardiology and neuromodulation, with the latter posting 12.7% sales growth. However, the company lowered its full-year adjusted EPS guidance to $3.28-$3.32 versus the Street estimate of $3.36, citing headwinds from Watchman device utilization slowdown and intensifying electrophysiology competition. Despite the guidance cut, multiple firms including UBS, Deutsche Bank, and RBC maintained buy ratings while trimming price targets. The Health Care Equipment sector rallied broadly on the day, with DexCom up 3.76%, Intuitive Surgical up 2.99%, and Medtronic up 2.21%, providing additional support.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BSX","symbol_name":"波士顿科学","start_time":0,"source_url":"","article_id":"1149687835","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1149687835","pubTimestamp":1786389710,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On August 11, Boston Scientific rose 3.01% in regular trading, trading at $50.795/share, with turnover of $692 million. The rally was driven by broad strength in the Health Care Equipment sector...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BSX":"波士顿科学"},"translate_title":"走势警报|波士顿科学常规交易中上涨 3.01%，板块走强和财报后复苏推动上涨","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BSX":1},"content_text":"On August 11, Boston Scientific rose 3.01% in regular trading, trading at $50.795/share, with turnover of $692 million. The rally was driven by broad strength in the Health Care Equipment sector combined with continued recovery following the company's better-than-expected Q2 earnings.Boston Scientific reported Q2 adjusted EPS of $0.86, beating the consensus estimate of $0.83 by 3.6%, while net sales of $5.44 billion also exceeded the $5.36 billion expected. The outperformance was fueled by strong growth in interventional cardiology and neuromodulation, with the latter posting 12.7% sales growth. However, the company lowered its full-year adjusted EPS guidance to $3.28-$3.32 versus the Street estimate of $3.36, citing headwinds from Watchman device utilization slowdown and intensifying electrophysiology competition. Despite the guidance cut, multiple firms including UBS, Deutsche Bank, and RBC maintained buy ratings while trimming price targets. The Health Care Equipment sector rallied broadly on the day, with DexCom up 3.76%, Intuitive Surgical up 2.99%, and Medtronic up 2.21%, providing additional support.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1149687835","isCrawlerRequest":true}